On Thursday, 20 November 2025, Wave Life Sciences (NASDAQ:WVE) presented at the Jefferies London Healthcare Conference 2025. The company shared its strategic focus on RNA medicine, highlighting ...

Females have two sex hormones. Males have been conceded but one, though male and female sex glands are analogous. Last week Dr. D. Roy McCullagh of the Cleveland Clinic Foundation reported in Science ...

iBio announces licensing agreement with AstralBio for a novel antibody targeting Activin E, potentially aiding weight loss and cardiometabolic health. Bio, Inc. has announced a licensing agreement ...

"Obesity is gradually eroding human health," and the global prevalence of obesity (BMI > 30) is predicted to reach 25 % by 2035, affecting nearly 1.9 billion people. The demand for medications to ...

iBio, Inc. has announced a collaboration with AstralBio Inc. to develop an innovative antibody targeting Activin E, a key factor in cardiometabolic disorders and obesity, using iBio's Machine-Learning ...

Obesity specialist Sixpeaks Bio AG emerged from stealth with $110 million in funding and an option to be acquired by Astrazeneca plc within the next two years, subject to filing an IND for the lead ...

BASEL, Switzerland--(BUSINESS WIRE)--SixPeaks Bio AG today emerged from stealth mode with a pipeline of therapies for healthy weight loss, including a potentially best-in-class dual-specific antibody ...

The obesity drugs taking the market by storm are great—leading to substantial weight loss for patients and potentially changing the course of future disease. But Regeneron’s Chief Scientific Officer ...

Chronic inflammation of the middle ear can cause several problems and complications that can affect a person’s hearing and balance. One such problem is the formation of a cholesteatoma, which is an ...

Over the last 25 years, our research program has focused on the identification and functional analysis of genes and pathways involved in mammalian reproduction. In many cases, we have taken a ...